Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 10—October 2014
Online Report

Dengue Expansion in Africa—Not Recognized or Not Happening?

Thomas JaenischComments to Author , Thomas Junghanss, Bridget Wills, Oliver J. Brady, Isabella Eckerle, Andrew Farlow, Simon I. Hay, Philip J. McCall, Jane P. Messina, Victor Ofula, Amadou Sall, Anavaj Sakuntabhai, Raman Velayudhan, G.R. William Wint, Herve Zeller, Harold S. Margolis, Osman Sankoh, and the Dengue in Africa Study Group
Author affiliations: Heidelberg University Hospital, Heidelberg, Germany (T. Jaenisch, T. Junghanss); Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (B. Wills); University of Oxford, Oxford, UK (O.J. Brady, A. Farlow, S.I. Hay, J.P. Messina); University of Bonn Medical Centre, Bonn, Germany (I. Eckerle); Liverpool School of Tropical Medicine, Liverpool, UK (P.J. McCall); US Army Medical Research Unit–Kenya, Nairobi, Kenya (V. Ofula); Institut Pasteur, Dakar, Senegal (A.A. Sall); Institut Pasteur, Paris, France (A. Sakuntabhai); World Health Organization, Geneva, Switzerland (R. Velayudhan); Environmental Research Group, Oxford (G.R.W. Wint); European Centre for Disease Control and Prevention, Stockholm, Sweden (H. Zeller); Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA (H.S. Margoulis); International Network for the Demographic Evaluation of Populations and Their Health, Accra, Ghana (O. Sankoh)

Main Article

Figure

Dengue risk for Africa based on environmental niche modeling (3) and location of International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH) member sites; Pasteur International Network Laboratories; and other reference laboratories (Centre International de Recherches Médicales de Franceville, Franceville, Gabon; Kenya Medical Research Institute/US Army Medical Research Unit, Nairobi, Kenya; and National Institute for Communicable Diseases, Johannesburg, South A

Figure. Dengue risk for Africa based on environmental niche modeling (3) and location of International Network for the Demographic Evaluation of Populations and Their Health (INDEPTH) member sites; Pasteur International Network Laboratories; and other reference laboratories (Centre International de Recherches Médicales de Franceville, Franceville, Gabon; Kenya Medical Research Institute/US Army Medical Research Unit, Nairobi, Kenya; and National Institute for Communicable Diseases, Johannesburg, South Africa).

Main Article

References
  1. World Health Organization. Dengue and severe dengue. Fact sheet # 117, 2012 [cited 2014 Jul 21]. http://www.who.int/mediacentre/factsheets/fs117/en/
  2. Brady  OJ, Gething  PW, Bhatt  S, Messina  JP, Brownstein  JS, Hoen  AG, Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6:e1760. . Epub 2012 Aug 7.DOI
  3. Bhatt  S, Gething  PW, Brady  OJ, Messina  JP, Farlow  AW, Moyes  CL, The global distribution and burden of dengue. Nature. 2013;496:5047 . DOI
  4. World Health Organization. 17 neglected tropical diseases [cited 2014 Jul 21]. http://www.who.int/neglected_diseases/diseases/en/
  5. Amarasinghe  A, Kuritsk  JN, Letson  GW, Margolis  HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011;17:134954 .PubMed
  6. Messina  JP, Brady  OJ, Scott  TW, Zou  C, Pigott  DM, Duda  KA, Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014;22:13846 . DOIPubMed
  7. Gautret  P, Simon  F, Hervius  AH, Bouchaud  O, Leparc-Goffart  I, Ninove  L, Dengue type 3 virus infections in European travellers returning from the Comoros and Zanzibar, February–April 2010. Euro Surveill. 2010;15:19541 .PubMed
  8. Gautret  P, Botelho-Nevers  E, Charrel  RN, Parola  P. Dengue virus infections in travellers returning from Benin to France, July–August 2010. Euro Surveill. 2010;15:19657 .PubMed
  9. Franco  L, Di  CA, Carletti  F, Vapalahti  O, Renaudat  C, Zeller  H, Recent expansion of dengue virus serotype 3 in west Africa. Euro Surveill. 2010;15:19490 .PubMed
  10. Centers for Disease Control and Prevention. Ongoing dengue epidemic—Angola, June 2013. MMWR Morb Mortal Wkly Rep. 2013;62:5047 .PubMed
  11. PROMED. Dengue/DHF update (33): Asia, Africa, Pacific - (2) Kenya (Mombasa). PROMEDmail; 2013 Apr 28. Report No.: 20130428.1676860 [cited 2014 Jul 23]. http://www.promedmail.org
  12. Sessions  OM, Khan  K, Hou  Y, Meltzer  E, Quam  M, Schwartz  E, Exploring the origin and potential for spread of the 2013 dengue outbreak in Luanda, Angola. Glob Health Action. 2013;6:21822.PubMed
  13. Moi  ML, Takasaki  T, Kotaki  A, Tajima  S, Lim  CK, Sakamoto  M, Importation of dengue virus type 3 to Japan from Tanzania and Côte d’Ivoire. Emerg Infect Dis. 2010;16:17702 . DOIPubMed
  14. Wichmann  O, Stark  K, Shu  PY, Niedrig  M, Frank  C, Huang  JH, Clinical features and pitfalls in the laboratory diagnosis of dengue in travellers. BMC Infect Dis. 2006;6:120 . DOIPubMed
  15. Franco  L, Palacios  G, Martinez  JA, Vazquez  A, Savji  N, De  OF, First report of sylvatic DENV-2-associated dengue hemorrhagic fever in west Africa. PLoS Negl Trop Dis. 2011;5:e1251 . DOIPubMed
  16. Vasilakis  N, Cardosa  J, Hanley  KA, Holmes  EC, Weaver  SC. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol. 2011;9:53241 . DOIPubMed
  17. Anders  KL, Hay  SI. Lessons from malaria control to help meet the rising challenge of dengue. Lancet Infect Dis. 2012;12:97784 . DOIPubMed
  18. Gubler  DJ. Dengue, urbanization and globalization: the unholy trinity of the 21(st) century. Trop Med Health. 2011;39(Suppl):311 . DOIPubMed
  19. Higa  Y. Dengue vectors and their spatial distribution. Trop Med Health. 2011;39(Suppl):1727 . DOIPubMed
  20. Paupy  C, Ollomo  B, Kamgang  B, Moutailler  S, Rousset  D, Demanou  M, Comparative role of Aedes albopictus and Aedes aegypti in the emergence of dengue and chikungunya in central Africa. Vector Borne Zoonotic Dis. 2010;10:25966 . DOIPubMed
  21. Simmons  CP, Farrar  JJ, Nguyen  V, Wills  B. Dengue. N Engl J Med. 2012;366:142332 . DOIPubMed
  22. Faye  O, Ba  Y, Faye  O, Talla  C, Diallo  D, Chen  R, Urban epidemic of dengue virus serotype 3 infection, Senegal, 2009. Emerg Infect Dis. 2014;20:4569 . DOIPubMed
  23. Centers for Disease Control and Prevention. Dengue in Angola. 2013 [cited 2014 Jul 21]. http://wwwnc.cdc.gov/travel/notices/watch/dengue-angola
  24. de la C Sierra B. Kourí G, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol. 2007;152:533–42 and. PubMed
  25. Halstead  SB, Streit  TG, Lafontant  JG, Putvatana  R, Russell  K, Sun  W, Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 2001;65:1803 .PubMed
  26. Bravo  JR, Guzman  MG, Kouri  GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg. 1987;81:81620 . DOIPubMed
  27. González  D, Castro  OE, Kouri  G, Perez  J, Martinez  E, Vazquez  S, Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001–2002. Int J Infect Dis. 2005;9:2805 . DOIPubMed
  28. Guzman  MG, Kouri  GP, Vasquez  S, Rosario  D, Bravo  JR, Valdez  L. DHF Epidemics in Cuba, 1981 and 1997: some interesting observations. Dengue Bull. 1999;23:3943.
  29. Morier  L, Kouri  G, Guzman  G, Soler  M. Antibody-dependent enhancement of dengue 2 virus in people of white descent in Cuba. Lancet. 1987;1:10289 . DOIPubMed
  30. Silva  LK, Blanton  RE, Parrado  AR, Melo  PS, Morato  VG, Reis  EA, Dengue hemorrhagic fever is associated with polymorphisms in JAK1. Eur J Hum Genet. 2010;18:12217 . DOIPubMed
  31. Gubler  DJ, Sather  GE, Kuno  G, Cabral  JR. Dengue 3 virus transmission in Africa. Am J Trop Med Hyg. 1986;35:12804 .PubMed
  32. Gubler  DJ. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med Singapore. 1998;27:22734 .PubMed
  33. Malik  A, Earhart  K, Mohareb  E, Saad  M, Saeed  M, Ageep  A, Dengue hemorrhagic fever outbreak in children in Port Sudan. J Infect Public Health. 2011;4:16 . DOIPubMed
  34. Petti  CA, Polage  CR, Quinn  TC, Ronald  AR, Sande  MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006;42:37782 . DOIPubMed
  35. Blacksell  SD, Jarman  RG, Gibbons  RV, Tanganuchitcharnchai  A, Mammen  MP Jr, Nisalak  A, Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin Vaccine Immunol. 2012;19:80410 . DOIPubMed
  36. Guzman  MG, Jaenisch  T, Gaczkowski  R, Ty Hang  VT, Sekaran  SD, Kroeger  A, Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis. 2010;4:e811 . DOIPubMed
  37. Hunsperger  EA, Yoksan  S, Buchy  P, Nguyen  VC, Sekaran  SD, Enria  DA, Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis. 2009;15:43640 . DOIPubMed
  38. Santiago  GA, Vergne  E, Quiles  Y, Cosme  J, Vazquez  J, Medina  JF, Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis. 2013;7:e2311 . DOIPubMed
  39. Wang  SM, Sekaran  SD. Early diagnosis of dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IGM, and IGG. Am J Trop Med Hyg. 2010;83:6905 . DOIPubMed
  40. Tricou  V, Vu  HT, Quynh  NV, Nguyen  CV, Tran  HT, Farrar  J, Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis. 2010;10:142 . DOIPubMed
  41. Blacksell  SD, Jarman  RG, Bailey  MS, Tanganuchitcharnchai  A, Jenjaroen  K, Gibbons  RV, Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol. 2011;18:2095101 . DOIPubMed
  42. Sánchez-Vargas  LA, Sanchez-Marce  EE, Vivanco-Cid  H. Evaluation of the SD BIOLINE dengue duo rapid test in the course of acute and convalescent dengue infections in a Mexican endemic region. Diagn Microbiol Infect Dis. 2014;78:36872 . DOIPubMed
  43. World Health Organization. WHO report on global surveillance of epidemic-prone infectious diseases: dengue and dengue haemorrhagic fever, 2014 [cited 2014 Jul 21]. http://www.who.int/csr/resources/publications/dengue/CSR_ISR_2000_1/en/index3.html
  44. Sankoh  O, Byass  P. The INDEPTH Network: filling vital gaps in global epidemiology. Int J Epidemiol. 2012;41:57988 . DOIPubMed
  45. Diallo  M, Sall  AA, Moncayo  AC, Ba  Y, Fernandez  Z, Ortiz  D, Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am J Trop Med Hyg. 2005;73:4459 .PubMed
  46. Brown  JE, McBride  CS, Johnson  P, Ritchie  S, Paupy  C, Bossin  H, Worldwide patterns of genetic differentiation imply multiple ‘domestications’ of Aedes aegypti, a major vector of human diseases. Proc Biol Sci. 2011;278:244654 . DOIPubMed
  47. Moore  M, Sylla  M, Goss  L, Burugu  MW, Sang  R, Kamau  LW, Dual African origins of global Aedes aegypti s.l. populations revealed by mitochondrial DNA. PLoS Negl Trop Dis. 2013;7:e2175 and. DOIPubMed
  48. Diallo  M, Ba  Y, Faye  O, Soumare  ML, Dia  I, Sall  AA. Vector competence of Aedes aegypti populations from Senegal for sylvatic and epidemic dengue 2 virus isolated in west Africa. Trans R Soc Trop Med Hyg. 2008;102:4938 . DOIPubMed
  49. Paupy  C, Brengues  C, Ndiath  O, Toty  C, Herve  JP, Simard  F. Morphological and genetic variability within Aedes aegypti in Niakhar, Senegal. Infect Genet Evol. 2010;10:47380 and. DOIPubMed
  50. Schoof  HF. Mating, resting habits and dispersal of Aedes aegypti. Bull World Health Organ. 1967;36:6001 .PubMed
  51. Lumsden  WH. The activtiy cycle of domestic Aedes (Stegomyia) aegypti (L.) (Diptera: Culicidae) in Southern Province, Tanganyika. Bull Entomol Res. 1957;48:76982. DOI
  52. Savage  HM, Ezike  VI, Nwankwo  AC, Spiegel  R, Miller  BR. First record of breeding populations of Aedes albopictus in continental Africa: implications for arboviral transmission. J Am Mosq Control Assoc. 1992;8:1013 .PubMed
  53. Kamgang  B, Nchoutpouen  E, Simard  F, Paupy  C. Notes on the blood-feeding behavior of Aedes albopictus (Diptera: Culicidae) in Cameroon. Parasit Vectors. 2012;5:57. PubMed
  54. Kamgang  B, Happi  JY, Boisier  P, Njiokou  F, Herve  JP, Simard  F, Geographic and ecological distribution of the dengue and chikungunya virus vectors Aedes aegypti and Aedes albopictus in three major Cameroonian towns. Med Vet Entomol. 2010;24:13241 . DOIPubMed
  55. World Health Organization. Vector management and delivery of vector control services. Dengue guidelines for diagnosis, treatment, prevention and control. 3rd ed. Geneva: The Organization 2009.
  56. Lenhart  A, Orelus  N, Maskill  R, Alexander  N, Streit  T, McCall  PJ. Insecticide-treated bednets to control dengue vectors: preliminary evidence from a controlled trial in Haiti. Trop Med Int Health. 2008;13:5667 . DOIPubMed
  57. Esu  E, Lenhart  A, Smith  L, Horstick  O. Effectiveness of peridomestic space spraying with insecticide on dengue transmission; systematic review. Trop Med Int Health. 2010;15:61931 .PubMed
  58. Greif  MJ, Dodoo  FN, Jayaraman  A. Urbanisation, poverty and sexual behaviour: the tale of five African cities. Urban Stud. 2011;48:94757 . DOIPubMed
  59. United Nations. World urbanization prospects. The 2011 revision. New York: United Nations; 2012.
  60. Badurdeen  S, Valladares  DB, Farrar  J, Gozzer  E, Kroeger  A, Kuswara  N, Sharing experiences: towards an evidence based model of dengue surveillance and outbreak response in Latin America and Asia. BMC Public Health. 2013;13:607 . DOIPubMed
  61. Zorlu  G, Fleck  F. Dengue vaccine roll-out: getting ahead of the game. Bull World Health Organ. 2011;89:4767 . DOIPubMed

Main Article

1Members of the Dengue in Africa Study Group are listed at the end of this article.

Page created: September 04, 2014
Page updated: September 04, 2014
Page reviewed: September 04, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external